NCT03595189View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetic Profile of an Infusion of Cilastatin in Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

August 9, 2018

Study Completion Date

August 9, 2018

Conditions

Dose Finding Study

Interventions

DRUG

Cilastatin

Dose escalation 3-hour single intravenous administration

DRUG

Placebo

3-hour single intravenous administration

Trial Locations (1)

28029

Clinical Trials Unit, School of Medicine, Universidad Autónoma de Madrid, Madrid

Sponsors

Lead Sponsor

Spherium Biomed

All Listed Sponsors

collaborator

Hospital Universitario La Paz

OTHER

lead

Spherium Biomed

INDUSTRY